Biomarker

Results: 1953



#Item
41p-medicine – Grant Agreement noD13.2 Concrete recommendations and findings on selected challenges in the selected diseases Deliverable NoConcrete recommendations and findings on selected challenges in t

p-medicine – Grant Agreement noD13.2 Concrete recommendations and findings on selected challenges in the selected diseases Deliverable NoConcrete recommendations and findings on selected challenges in t

Add to Reading List

Source URL: p-medicine.eu

Language: English - Date: 2013-02-13 06:22:25
42PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

Add to Reading List

Source URL: www.oncodesign.com

Language: English - Date: 2016-07-12 12:51:48
43BTXNGS142_Met Solution Test Req_v27_front

BTXNGS142_Met Solution Test Req_v27_front

Add to Reading List

Source URL: www.cancertypeid.com

Language: English - Date: 2016-05-06 14:12:18
44FASN inhibitor TVB-2640 shows pharmacodynamic effect and evidence of clinical activity in KRAS mutant NSCLC patients in a Phase 1 study Marie O’Farrell, Tim Heuer, Katharine Grimmer, Richard Crowley, Joanna Waszczuk, M

FASN inhibitor TVB-2640 shows pharmacodynamic effect and evidence of clinical activity in KRAS mutant NSCLC patients in a Phase 1 study Marie O’Farrell, Tim Heuer, Katharine Grimmer, Richard Crowley, Joanna Waszczuk, M

Add to Reading List

Source URL: www.3vbio.com

Language: English - Date: 2016-04-19 06:39:33
45Mcm5 ELISA Bladder Cancer Test A non-invasive, simple diagnostic test for bladder cancer launching in 2016 Overview The diagnosis of bladder cancer, a disease affecting over 150,000 individuals in Europe alone each year,

Mcm5 ELISA Bladder Cancer Test A non-invasive, simple diagnostic test for bladder cancer launching in 2016 Overview The diagnosis of bladder cancer, a disease affecting over 150,000 individuals in Europe alone each year,

Add to Reading List

Source URL: www.arquerdx.com

Language: English - Date: 2016-04-05 13:47:03
46Lascco Announces Granted US Patent Protecting its Biomarker PSP for the Diagnosis of Sepsis June 28, 2013 GENEVA, SWITZERLAND -- Lascco SA announced today today that the United States Patent and Trademark Office (USPTO)

Lascco Announces Granted US Patent Protecting its Biomarker PSP for the Diagnosis of Sepsis June 28, 2013 GENEVA, SWITZERLAND -- Lascco SA announced today today that the United States Patent and Trademark Office (USPTO)

Add to Reading List

Source URL: www.lascco.com

Language: English - Date: 2013-07-02 10:23:28
47Biomarqueurs du futur en réanimation Séminaire du Comité d’Interface Inserm/SFAR/SRLF Institut Pasteur 15 décembreJean-Paul Mira

Biomarqueurs du futur en réanimation Séminaire du Comité d’Interface Inserm/SFAR/SRLF Institut Pasteur 15 décembreJean-Paul Mira

Add to Reading List

Source URL: www.comites-d-interface.inserm.fr

Language: English - Date: 2010-10-28 05:51:07
48Microsoft Word - KIDNEY_5.12.201_def.doc

Microsoft Word - KIDNEY_5.12.201_def.doc

Add to Reading List

Source URL: www.neurotune.com

Language: English - Date: 2011-12-08 07:40:10
49White Paper S pecial Focus I ssue: B ioanalysis of biomarkers For reprint orders, please contact

White Paper S pecial Focus I ssue: B ioanalysis of biomarkers For reprint orders, please contact

Add to Reading List

Source URL: www.atlanbio.com

Language: English - Date: 2015-06-08 04:15:48
50#3129 Predictive biomarker identification for response of vantictumab (OMP-18R5; anti-Frizzled) using primary patient-derived human pancreatic tumor xenografts Chun Zhang, Fiore Cattaruzza, Pete Yeung, Wan-Ching Yen, Ma

#3129 Predictive biomarker identification for response of vantictumab (OMP-18R5; anti-Frizzled) using primary patient-derived human pancreatic tumor xenografts Chun Zhang, Fiore Cattaruzza, Pete Yeung, Wan-Ching Yen, Ma

Add to Reading List

Source URL: posters.omed.s3.amazonaws.com

Language: English - Date: 2016-04-18 15:47:23